|
Mar 13
|
Is A Recession Coming in 2025? Where to Invest Now
|
|
Mar 13
|
NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand
|
|
Mar 13
|
Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update
|
|
Mar 13
|
Wall Street's Biggest Novo Nordisk Bear Just Flipped--Here's Why He Says It's Time to Buy
|
|
Mar 13
|
UiPath plunges on weak outlook, Novo Nordisk upgrade: Top Stocks
|
|
Mar 13
|
How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
|
|
Mar 13
|
Novo Nordisk Skeptic Finally Upgrades Stock After Drop From Peak
|
|
Mar 12
|
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
|
|
Mar 12
|
Compounded Wegovy and Zepbound may disappear under new FDA rules
|
|
Mar 12
|
Roche, Zealand sign deal: What it means for weight loss drug space
|
|
Mar 12
|
Novo Nordisk Is Falling. Competition Is a Killer.
|
|
Mar 12
|
Novo Nordisk, Starbucks shares slumping: Trending Tickers
|
|
Mar 12
|
iRobot, Target, Novo Nordisk vs. Roche: Market Minute
|
|
Mar 12
|
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
|
|
Mar 12
|
Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%
|
|
Mar 12
|
Novo Nordisk Stock Slides After Roche Strikes Weight-Loss Deal
|
|
Mar 12
|
Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly
|
|
Mar 12
|
VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply
|
|
Mar 12
|
NovoNordisk stock falls on Roche-Zealand pact; Jefferies cuts target
|
|
Mar 11
|
Viking strikes $150m deal to secure supply of obesity drug
|